S U M M A R Y We have investigated whether plasma exchange in myasthenia gravis synergises with additional immunosuppressive drug therapy (azathioprine, cyclophosphamide or cytosine arabinoside). Serum anti-acetylcholine receptor (AChR) antibody titres were followed over 28 days after a course of PE in 20 patients, of whom 17 were taking 20-80 mg prednisone on alternate days. No significant difference was observed in mean anti-AChR antibody recovery following plasma exchange with and without additional immunosuppressive therapy. In paired studies where patients served as their own controls, mean anti-AChR recovery with and without azathioprine or cytosine arabinoside showed no significant differences. Anti-AChR recovery rates after large and small plasma exchange courses also did not differ significantly. Prolonged administration of azathioprine reduced antibody titres independently of plasma exchange. These results fail to demonstrate significant synergy between plasma exchange and the additional immunosuppressive drugs used, and suggest that the effects of plasma exchange were transient.
The disorder of neuromuscular transmission in myasthenia gravis can be accounted for by a decrease in the number of functional acetylcholine receptors (AChRs)1 2 and anti-AChR antibodies have been implicated in the loss of AChR. 4 Plasma exchange can produce a substantial reduction in serum anti-AChR and is assoCiated with corresponding short-term clinical improvement. S When combined with immunosupp-essive drug treatment, plasma exchange may be followed by prolonged remission. It has been implied that plasma exchange may play an essential part in this response,'" but controlled data are lacking. Immunosuppressive drugs alone can induce remission in myas.henia gravis"' 11 Synergy between plasma exchange and immunosuppressive drug treatment should be most evident in the period immediately following plasma exchange, as has been demonstrated in an animal model.12 By causing antibody producing cells to proliferate1" plasma exchange may render them more vulnerable to immunosuppressive drug therapy.', In this controlled study, we have analysed the serum anti-AChR antibody responses in the period immediately following plasma exchange and have failed to demonstrate a synergistic action with immunosuppressive drug therapy.
Patients and methods
Twenty patients, 10 males and 10 females aged 18-68 years, wvere studied. All had the generalised acquired form of the disease (Osserman14 grade IIB six cases, grade III six cases, grade IV eight cases); duration ranged from six months to 23 years. All were receiving acetylcholinesterase inhibitors and had elevated serum titres of anti-AChR antibody (range 0,7-120; normal <0 2 nmol/l). Eighteen patients underwent thymectomy before the period of study and two afterwards. Nine patients had thymic hyperplasia and 1 I had thymomas. 469 Plasma exchange Plasma exchange was performed using a Haemonetics 30 cell separator. Two to four litres of plasma were exchanged on three to 10 occasions over three to 14 days. Plasma was replaced isovolumetrically with human plasma protein fraction (PPF, Blood Products Laboratories) or Buminate (Travenol Limited) and up to 50% normal saline, Ringer lactate or Dextran 70. Calcium and potassium were added to physiological concentrations. Between eight and 32 litres of plasma were exchanged via forearm or femoral veins, arteriovenous fistula, or arteriovenous shunt. Forty-nine courses of plasma exchange were performed; 26 were classified as "small" (<12 1 mean 10-0±0-5 1, 2 SEM) and 13 as "large" (>14 1 mean 18,3±3-0 1). The remaining 10 courses formed part of a paired study in which the size of the exchange was deliberately altered and these data are analysed separately.
A nti-AChR antibody titres
Serum anti-AChR titres were measured by an immunoprecipitation method using Triton X100 solubilised AChR obtained from amputated human calf muscle, as previously described.7 Measurements were made on single serum samples drawn immediately before exchange, 24 hours after a course of exchange, on average twice weekly for four weeks following exchange and less frequently thereafter.
Immunosuppression
Seventeen of the 20 patients received prednisone (20-80 mg on alternate days) throughout the study period. The dose was unchanged over this period in all but three. Additional immunosuppression comprised either azathioprine, cyclophosphamide or cytosine arabinoside (AraC). Ten patients received 12 courses of plasma exchange without additional immunosuppression. Twelve patients received 15 courses of plasma exchange with azathioprine 2-5 mg/kg per day orally. Six patients received seven courses of plasma exchange with cyclophosphamide 2 5 mg/kg per day orally, and five patients underwent plasma exchange followed by AraC intravenously for three to four days (see below). These groups did not differ significantly with respect to age, sex, thymic state, initial antibody titre, clinical grade, duration of disease or prednisone dosage. Immunosuppressive treatment was started on or before the first day of plasma exchange; the majority of patients had been taking the immunosuppressive drug for several months before plasma exchange. In most patients receiving cyclophosphamide, azathioprine 2-5 mg/kg per day orally was substituted after six weeks.
Paired comparisons
Paired comparisons in which patients served as their own controls were undertaken further to evaluate the response to plasma exchange. Three treatments were tested while all other treatment conditions were kept constant. (i) Azathioprine: plasma exchange with and without azathioprine (2 5 mg/kg) was carried out in six patients.
(ii) AraC: plasma exchange with and without AraC was investigated in five patients. The course of AraC was started on the day following a course of plasma exchange. In four patients who were also receiving prednisone and azathioprine, it was given as 1 mg/kg bolus daily for four days and in one patient (on no other treatment) 5 mg/kg was given for three days which produced a severe leucopenia. (iii) Size of plasma exchange: In five patients small courses of exchange (three to five daily exchanges over five days) were compared with large courses of exchange (10 exchanges over 12 days). The size of each daily exchange was constant (volume of plasma equal to plasma volume calculated as 5 % body weight) and no change in immunosuppressive treatment was made during this study.
Variables analysed
Data for individual patients was normalised for each exchange to a pre-exchange value of 100% and the following variables were analysed: (1) Serum antiAChR antibody at 24 hours, 28 days and 112 days after the end of a course of plasma exchange, (2) the mean rate of rise in serum anti-AChR antibody titre during the four weeks following plasma exchange, derived from the anti-AChR antibody titres at 24 hours and 28 days after plasma exchange, (3) halftime (ti) for anti-AChR antibody recovery after plasma exchange; that is the time for antibody titre to rise to a value halfway between the pre-exchange and immediately post-exchange titres measured from individual plots of serial post-PE anti-AChR values. 
Clinical assessment

Discussion
Our results confirm that plasma exchange can reduce serum anti-AChR antibody by about 60% in a few days. Anti-AChR titres provided an appropriate index of clinical effectiveness because as previously reported there was a short-term inverse correlation with muscle power in individuals.6A8 However, the benefits of plasma exchange were of limited duration and, with the exception of large exchanges, anti-AChR antibody returned to within 10% of pre-exchange values by 28 days, and there was an associated clinical decline. None of the treatments we have described in this paper significantly affected this rapid recovery of anti-AChR antibody after plasma exchange. The use of t' as a measure of antibody recovery after plasma exchange can be criticised on the grounds that re-equilibration between intravascular and extravascular compartments and the size of the exchange may substantially influence its value. We have therefore also evaluated the mean 
